Retrospective Study
Copyright ©The Author(s) 2025.
World J Hepatol. Aug 27, 2025; 17(8): 108333
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.108333
Table 1 General information of the normal and abnormal groups, n (%)
Parameter
Normal group (n = 3553)
Abnormal group (n = 167)
Statistic
P value
Gender, male1037 (29.19)88 (52.69)χ² = 41.78< 0.01
Age, year56.00 (47.00, 66.00)59.00 (50.00, 67.00)Z = -1.510.13
Weight, kg58.00 (52.00, 65.00)59.00 (52.35, 66.50)Z = -0.930.35
BMI, kg/m222.89 (20.62, 25.33)22.66 (20.37, 25.56)Z = -0.310.76
Past medical history
High blood pressure1126 (31.69)51 (30.54)χ² = 0.100.75
Diabetes2487 (70.00)116 (69.46)χ² = 0.020.88
Coronary heart disease1480 (41.65)72 (43.11)χ² = 0.140.71
Cerebral infarction90 (2.53)2 (1.20)χ² = 0.690.41
Viral hepatitis211 (5.94)13 (7.78)χ² = 0.960.33
Chronic hepatitis17 (0.48)1 (0.60)-0.56
Liver cirrhosis12 (0.34)0 (0.00)-1.00
Hyperlipidemia140 (3.94)10 (5.99)χ² = 1.730.19
COPD11 (0.31)1 (0.60)-0.42
Chronic kidney disease91 (2.56)6 (3.59)χ² = 0.320.57
Table 2 Results of laboratory testing analysis in the normal and abnormal groups
Parameter, unit
Normal group (n = 3553)
Abnormal group (n = 167)
Statistic
P value
AST, U/L18.00 (15.00, 22.00)30.00 (20.00, 52.00)Z = -12.42< 0.01
ALT, U/L15.00 (11.00, 21.00)29.00 (17.00, 69.00)Z = -10.83< 0.01
ALP, g/L70.00 (57.00, 87.00)78.00 (63.64, 111.00)Z = -4.78< 0.01
GGT, U/L19.00 (14.00, 30.00)38.00 (21.00, 82.50)Z = -9.77< 0.01
Tbil, μmol/L8.60 (6.00, 12.10)10.30 (7.10, 15.60)Z = -4.23< 0.01
Total protein, g/L71.30 (68.80, 74.60)70.90 (67.05, 72.70)Z = -3.35< 0.01
Albumin, g/L42.90 (40.20, 45.50)41.50 (38.20, 44.45)Z = -4.23< 0.01
Globulin, g/L27.20 (25.70, 30.40)27.20 (25.50, 30.60)Z = -0.450.65
Glu, mmol/L5.31 (4.78, 6.36)5.77 (5.00, 6.88)Z = -3.11< 0.01
HB, g/L125.00 (109.00, 136.00)125.00 (106.50, 140.50)Z = -0.900.37
WBC, × 109/L6.35 (5.27, 7.72)6.37 (5.30, 7.94)Z = -0.530.60
N, × 109/L3.94 (3.07, 5.08)3.92 (2.90, 5.13)Z = -0.280.78
RBC, × 1012/L4.33 (3.95, 4.68)4.26 (3.74, 4.68)Z = -1.850.06
PLT, × 1012/L259.00 (215.00, 314.00)232.00 (178.00, 278.00)Z = -4.72< 0.01
K+ , mmol/L4.00 (3.80, 4.20)4.01 (3.77, 4.21)Z = -0.140.89
Na+ , mmol/L140.00 (139.00, 142.00)140.00 (139.00, 142.00)Z = -1.200.23
Ca2+ , mmol/L2.30 (2.30, 2.30)2.30 (2.30, 2.30)Z = -0.050.96
CL- , mmol/L103.80 (102.10, 105.50)103.70 (101.60, 105.40)Z = -0.860.39
TC, mmol/L4.71 (4.49, 4.91)4.71 (4.46, 4.75)Z = -0.420.67
Tg, mmol/L1.35 (1.19, 1.45)1.35 (1.29, 1.60)Z = -1.290.20
LDL, mmol/L3.06 (2.87, 3.20)3.06 (2.79, 3.06)Z = -1.140.25
HDL, mmol/L1.18 (1.14, 1.26)1.18 (0.99, 1.18)Z = -2.96< 0.01
Uric, mmol/L350.00 (350.00, 350.00)350.00 (350.00, 350.00)Z = -0.740.46
EGFR, mmol/L94.75 (81.14, 106.41)93.72 (83.34, 104.34)Z = -0.200.84
Urea, mmol/L4.68 (3.72, 5.75)4.81 (3.91, 5.81)Z = -0.970.33
Cr, mmol/L65.00 (56.00, 78.00)69.00 (58.00, 83.00)Z = -1.980.05
Table 3 Intraoperative data analysis for the normal and abnormal groups
Parameter
Normal group (n = 3553)
Abnormal group (n = 167)
Statistic
P value
Head and neck surgery14 (0.39)3 (1.80)-0.04
Operation on the spine and limbs643 (18.10)42 (25.15)χ² = 5.280.02
Operation on the esophagus, gastrointestinal tract, pancreas, spleen, and appendix907 (25.53)88 (52.69)χ² = 60.08< .01
Operation on the kidneys, bladder, and ureter218 (6.14)8 (4.79)χ² = 0.510.48
Operation on the uterus, ovaries, and fallopian tube1771 (49.85)26 (15.57)χ² = 75.04< 0.01
Time of operation239.00 (205.00, 288.00)290.00 (232.00, 359.00)Z = -7.16< 0.01
Anesthesia time, minute295.00 (257.00, 346.00)352.00 (290.00, 417.00)Z = -7.50< 0.01
Length of hospital stay, day13.00 (9.00, 18.00)16.00 (11.00, 22.00)Z = -5.24< 0.01
ASA rating
I169 (4.76)5 (2.99)χ² = 1.110.29
II2709 (76.25)115 (68.86)χ² = 4.760.03
III671 (18.89)45 (26.95)χ² = 6.67< 0.01
IV4 (0.11)2 (1.20)-0.03
Sufentanil, μg10.00 (5.00, 15.00)10.00 (5.00, 15.00)Z = -1.310.19
Whether to pump remifentanil3131 (88.12)164 (98.20)χ² = 16.02< 0.01
Rocuronium, mg2.49 ± 10.762.94 ± 10.66t = -0.530.59
Etomidate, mg6.88 ± 16.138.70 ± 19.38t = -1.410.16
Whether to pump propofol2681 (75.46)119 (71.26)χ² = 1.510.22
Dosage of intravenous propofol, mg35.40 ± 153.5430.48 ± 107.01t = 0.410.68
Dexmedetomidine, μg4.09 ± 12.963.92 ± 13.37t = 0.170.87
Sevoflurane, mL60.00 (40.00, 100.00)80.00 (50.00, 120.00)Z = -4.29< 0.01
Table 4 Results of the logistic regression analysis
Parameter
β
Se
Wald χ2
P value
Or
Lower limit of 95%CI
95%CI upper bound
Age, year-0.0110.0072.0180.1550.9890.9751.004
Sex, male-0.0430.2270.0350.8510.9580.6141.495
Anesthesia time, minute0.0050.00125.56401.0051.0031.007
ASA II-0.0270.2150.0160.8990.9730.6381.483
Whether to pump remifentanil1.5280.6236.0230.0144.6101.36015.624
Cr, mmol/L-0.0020.0030.5080.4760.9980.9921.004
Sufentanil0.0080.00216.3970.001.0081.0041.012
AST, U/L0.0420.00921.6330.001.0431.0251.062
ALT, U/L0.0190.0069.4110.0021.0191.0071.031
ALP, g/L-0.0020.0020.3710.5430.9980.9941.003
GGT, U/L0.0030.0023.3970.0651.0031.001.007
TBIL, μmol/L0.0150.0111.9070.1671.0150.9941.037
Albumin, g/L-0.0130.0210.3850.5350.9870.9461.029
PLT, × 1012/L-0.0040.00110.6240.0010.9960.9940.999
Glu, mmol/L0.0110.0410.0780.781.0120.9341.096
Length of hospital stay, day0.0140.0083.3710.0661.0140.999
Operation on the esophagus, gastrointestinal tract, pancreas, spleen, and appendix0.8240.22912.9880.002.2791.4563.567
Operation on the uterus, ovaries, and fallopian tube-0.7730.3106.2310.0130.4610.2510.847
Constant-6.8471.4622.0090.000.001